Negotiating and Structuring Strategic Alliances
June 01, 2002
The job of many a biotech CEO is scrambling to find and secure funds to support the company’s development projects. For many biopharmaceutical companies in early development stages, collaboration with “big pharma” is a compelling answer to the cashflow problem. But strategic alliances should benefit those on both sides of the negotiating table. For a full copy of this article, please refer to BioPharm’s website www.biopharm-mag.com/biopharm/data/articlestandard/biopharm/262002/22989/article.pdf.
